Aims and Scope
Advances in Therapy is a monthly peer-reviewed medical journal covering clinical medicine, especially research on pharmaceuticals. The Managing Editor is Clare Shepherd. The journal publishes original clinical research papers and review articles. The journal was established in 1984 and published by Health Communications. Since 2008 it has been published by Springer Science+Business Media.
Key Metrics
5
CiteScore
CiteScore
CiteScore measures average citations received per document published in the serial.
0.005 - 0.01
Eigenfactor
Eigenfactor
Eigenfactor Score measures the number of times articles from the journal published in the past five years have been cited. This does not include self citations.
< 5
Impact Factor
Impact Factor
Impact factor of a journal is calculated by dividing the number of current year citations to the source items published in that journal during the previous two years.
74
H index
H-Index
Journal's h-index reflects the collective citation impact of the authors publishing in the journal. The h-index is defined as the maximum value of h such that the given journal has published at least h papers that have each been cited at least h times.
0.88
5-Year SI
5-year SI
- 0.91 2-year SI
- 0.87 Lifetime SI
Scite Index
Scite Index
scite Index is the ratio of citations supporting research which is published in the journal to sum of citations either supporting or contrasting the research published in the journal for the same time period. Minimum 100 supporting citations required.
Q1
Pharmacology (medical)
SJR
- Q1 Pharmacology (medical)
- Q1 Medicine (miscellaneous)
SJR
SJR
SCImago Journal Rank measures weighted citations received by the serial. Citation weighting depends on subject field and prestige (SJR) of the citing serial.
1.37
SNIP
SNIP
Source Normalized Impact per Paper measures actual citations received relative to citations expected for the serial’s subject field.
3 Mo
Time to Publish
Time to Publish
Based on turnaround time from submission to publication for papers (articles & reviews) published in 2022 and for journals with a sample of more than 10 papers.
Topics Covered
- Cancer
- Body mass index
- Clinical trial
- Randomized controlled trial
- Rheumatoid arthritis
- Renal function
- Anemia
- Type 2 diabetes
- Atrial fibrillation
- Psoriatic arthritis
- Migraine
- Blood pressure
- Confidence interval
- Glaucoma
- Bupivacaine
- Placebo
- Epidermal growth factor receptor
- Hepatocellular carcinoma
- Overall survival
- Multiple sclerosis
Journal Specifications
| Overview | |
| Publisher | SPRINGER |
| Language | English |
| Frequency | Monthly |
| General Details | |
| Language | English |
| Frequency | Monthly |
| Publication Start Year | 1984 |
| Publisher URL | Visit website |
| Website URL | Visit website |
Planning to publish in Advances in Therapy ?
Upload your Manuscript to get
- Degree of match
- Common matching concepts
- Additional journal recommendations
Looking for the right journals to submit your mansucript?
Upload your manuscript and get a submission readiness score and other journal recommendations.
Check my PaperRecently Published Papers
-
Full paper
Correction: Beyond Response: Aiming for Quality Remission in Depression.
- 12 Jul 24
- Advances in therapy
-
Full paper
A DPC Database Study on the Safety of Atezolizumab/Carboplatin/Etoposide in Extensive-Disease Small Cell Lung Cancer in Japanese Patients.
- 12 Jul 24
- Advances in therapy
-
Full paper
A DPC Database Study on the Safety of Atezolizumab/Bevacizumab/Carboplatin/Paclitaxel in Non-small Cell Lung Cancer in Japanese Patients.
- 11 Jul 24
- Advances in therapy
-
Full paper
Momelotinib versus Continued Ruxolitinib or Best Available Therapy in JAK Inhibitor-Experienced Patients with Myelofibrosis and Anemia: Subgroup Analysis of SIMPLIFY-2.
- 11 Jul 24
- Advances in therapy
-
Full paper
Impacts of X-linked Retinitis Pigmentosa and Patient Pathways in European Countries: Results from the Cross-sectional EXPLORE XLRP-1 Physician Survey.
- 8 Jul 24
- Advances in therapy
-
Full paper
Risk for Mortality in High versus Low Antiparkinsonian Therapy Dose During the First Year of Parkinson's Disease: A Real-World Study.
- 8 Jul 24
- Advances in therapy
Scite analysis
Powered by scite_
3.9k articles received 60.2k citations see all
- 2,619 Supporting
- 54,811 Mentioning
- 390 Contrasting
Editorial notices
- 0 Retractions
- 0 Withdrawals
- 117 Corrections
- 128 Errata
- 0 Expression of Concern
Time To Publish
Time to Publish
Based on turnaround time from submission to publication for papers (articles & reviews) published in 2022 and for journals with a sample of more than 10 papers.
Time to Publish
Based on turnaround time from submission to publication for papers (articles & reviews) published in 2022 and for journals with a sample of more than 10 papers.
% of papers by time taken from submission to publication
0 to 3 months
56%
4 to 6 months
39%
7 to 9 months
4%
Above 9 months
1%
Did you find this useful?
Thank you for your feedback.
FAQs
How long has Advances in Therapy been actively publishing?
Advances in Therapy has been in operation since 1984 till date.
What is the publishing frequency of Advances in Therapy ?
Advances in Therapy published with a Monthly frequency.
How many articles did Advances in Therapy publish last years ?
In 2023, Advances in Therapy published 343 articles.
What is the eISSN & pISSN for Advances in Therapy ?
For Advances in Therapy,eISSN is 1865-8652 and pISSN is0741-238X.
What is Citescore for Advances in Therapy ?
Citescore for Advances in Therapy is 5.
What is H index for Advances in Therapy ?
H index for Advances in Therapy is 74.
What is SNIP score for Advances in Therapy ?
SNIP score for Advances in Therapy is 1.37.
What is the SJR for Advances in Therapy ?
SJR for Advances in Therapy is Q1.
Who is the publisher of Advances in Therapy ?
SPRINGER is the publisher of Advances in Therapy.